Identification, immunogenicity, and cross-reactivity of type IV pilin and pilin-like proteins from Clostridium difficile

Pathogens and Disease

Volumn 71, Issue 3, 2014, Pages 302-314

  Maldarelli, Grace A ^a   De Masi, Leon ^a   von Rosenvinge, Erik C ^a,b   Carter, Mihaela ^a   Donnenberg, Michael S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibodies; Clostridium difficile; Cross reactivity; Immunogenicity; Pilin proteins; Type IV pili

Indexed keywords

PILIN; PILIN LIKE PROTEIN; TYPE IV PILIN PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; FIMBRIA PROTEIN; SUBUNIT VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM DIFFICILE; CROSS REACTION; GENE CLUSTER; GENE NOMENCLATURE; GENE SEQUENCE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; ANIMAL; BLOOD; GENETIC SELECTION; GENETIC VARIABILITY; GENETICS; GUINEA PIG; IMMUNOLOGY; MOLECULAR EVOLUTION; MUTATION; PEPTOCLOSTRIDIUM DIFFICILE; RABBIT;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CLOSTRIDIUM DIFFICILE; EVOLUTION, MOLECULAR; FIMBRIAE PROTEINS; GENETIC VARIATION; GUINEA PIGS; MICE; MUTATION; RABBITS; SELECTION, GENETIC; VACCINES, SUBUNIT;

EID: 84905702476     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12137     Document Type: Article

References (41)

1. Alm RA & Mattick JS (1995) Identification of a gene, pilV, required for type 4 fimbrial biogenesis in Pseudomonas aeruginosa, whose product possesses a pre-pilin-like leader sequence. Mol Microbiol 16: 485-496.
2. Alm RA & Mattick JS (1996) Identification of two genes with prepilin-like leader sequences involved in type 4 fimbrial biogenesis in Pseudomonas aeruginosa. J Bacteriol 178: 3809-3817.
3. Alm RA, Hallinan JP, Watson AA & Mattick JS (1996) Fimbrial biogenesis genes of Pseudomonas aeruginosa: PilW and pilX increase the similarity of type 4 fimbriae to the GSP protein-secretion systems and pilY1 encodes a gonococcal PilC homologue. Mol Microbiol 22: 161-173.
4. Attridge SR, Wallerstrom G, Qadri F & Svennerholm AM (2004) Detection of antibodies to toxin-coregulated pili in sera from cholera patients. Infect Immun 72: 1824-1827.
5. Blank TE, Zhong H, Bell AL, Whittam TS & Donnenberg MS (2000) Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains. Infect Immun 68: 7028-7038.
6. Borriello SP, Davies HA & Barclay FE (1988) Detection of fimbriae amongst strains of Clostridium difficile. FEMS Microbiol Lett 49: 65-67.
7. Boslego JW, Tramont EC, Chung RC et al. (1991) Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 9: 154-162.
8. Craig L, Taylor RK, Pique ME, Adair BD, Arvai AS, Singh M et al. (2003) Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin. Mol Cell 11: 1139-1150.
9. Craig L, Pique ME & Tainer JA (2004) Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol 2: 363-378.
10. Craig L, Volkmann N, Arvai AS, Pique ME, Yeager M, Egelman EH & Tainer JA (2006) Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol Cell 23: 651-662.
11. Fernandes PJ, Guo Q & Donnenberg MS (2007a) Functional consequences of sequence variation in bundlin, the enteropathogenic Escherichia coli type IV pilin protein. Infect Immun 75: 4687-4696.
12. Fernandes PJ, Guo Q, Waag DM & Donnenberg MS (2007b) The Type IV Pilin of Burkholderia mallei Is Highly Immunogenic but Fails To Protect against Lethal Aerosol Challenge in a Murine Model. Infect Immun 75: 3027-3032.
13. Finlay BB & Falkow S (1997) Common themes in microbial pathogenicity revisited. Microbiol Rev 61: 136-169.
14. Forest KT, Bernstein SL, Getzoff ED, So M, Tribbick G, Geysen HM et al. (1996) Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies. Infect Immun 64: 644-652.
15. Giltner CL, Habash M & Burrows LL (2010) Pseudomonas aeruginosa minor pilins are incorporated into type IV pili. J Mol Biol 398: 444-461.
16. Goulding D, Thompson H, Emerson J, Fairweather NF, Dougan G & Douce GR (2009) Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1. Infect Immun 77: 5478-5485.
17. Hall TIC & O'Toole E (1935) Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 49: 390-402.
18. Imam S, Chen Z, Roos DS & Pohlschröder M (2011) Identification of surprisingly diverse type IV pili, across a broad range of gram-positive bacteria. PLoS ONE 6: e28919.
19. Kelly CP & LaMont JT (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359: 1932-1940.
20. Koga T, Ishimoto K & Lory S (1993) Genetic and functional characterization of the gene cluster specifying expression of Pseudomonas aeruginosa pili. Infect Immun 61: 1371-1377.
21. Korotkov KV & Hol WG (2008) Structure of the GspK-GspI-GspJ complex from the enterotoxigenic Escherichia coli type 2 secretion system. Nat Struct Mol Biol 15: 462-468.
22. Kotloff KL, Wasserman SS, Losonsky GA, Thomas W Jr, Nichols R, Edelman R et al. (2001) Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun 69: 988-995.
23. Lepper AWD, Atwell JL, Lehrbach PR, Schwartzkoff CL, Egerton JR & Tennent JM (1995) The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Vet Microbiol 45: 129-138.
24. Martinez MB, Taddei CR, Ruiz-Tagle A, Trabulsi LR & Girón JA (1999) Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants. J Infect Dis 179: 269-274.
25. Melville S & Craig L (2013) Type IV Pili in Gram-Positive Bacteria. Microbiol Mol Biol Rev 77: 323-341.
26. O'Toole GA & Kolter R (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30: 295-304.
27. Parge HE, Forest KT, Hickey MJ, Christensen DA, Getzoff ED & Tainer JA (1995) Structure of the fibre-forming protein pilin at 2.6 Å resolution. Nature 378: 32-38.
28. Piepenbrink KH, Maldarelli GA, Martinez de la Pena CF, Mulvey GL, Snyder GA, De Masi L, von Rosenvinge EC, Guenther S, Armstrong GD, Donnenberg MS & Sundberg EJ (in press) Structure of Clostridium difficile PilJ exhibits unprecedented divergence from known type IV pilins. J Biol Chem. doi: 10.1074/jbc.M113.534404.
29. Pizarro-Cerdá J & Cossart P (2006) Bacterial adhesion and entry into host cells. Cell 124: 715-727.
30. Stewart DJ, Clark BL, Peterson JE, Emery DL, Smith EF, Griffiths DA & O'Donnell IJ (1985) The protection given by pilus and whole cell vaccines of Bacteroides nodosus strain 198 against ovine foot-rot induced by strains of different serogroups. Aust Vet J 62: 153-159.
31. Stone KD, Zhang H-Z, Carlson LK & Donnenberg MS (1996) A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for biogenesis of a type IV pilus. Mol Microbiol 20: 325-337.
32. Strom MS, Nunn DN & Lory S (1993) A single bifunctional enzyme, PilD, catalyzes cleavage and N-methylation of proteins belonging to the type IV pilin family. P Natl Acad Sci USA 90: 2404-2408.
33. Sun D, Mekalanos JJ & Taylor RK (1989) Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis 161: 1231-1236.
34. Tacket CO, Taylor RK, Losonsky G, Lim Y, Nataro JP, Kaper JB & Levine MM (1998) Investigation of the roles of toxin-coregulated pili and mannose- sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect Immun 66: 692-695.
35. Varga JJ, Nguyen V, O'Brien DK, Rodgers K, Walker RA & Melville SB (2006) Type IV pili-dependent gliding motility in the Gram-positive pathogen Clostridium perfringens and other Clostridia. Mol Microbiol 62: 680-694.
36. Voss E, Manning PA & Attridge SR (1996) The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor. Microb Pathog 20: 141-153.
37. Wang H, Sun X, Zhang Y, Li S, Chen K, Shi L et al. (2012) A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun 80: 2678-2688.
38. Whitchurch CB, Hobbs M, Livingston SP, Krishnapillai V & Mattick JS (1991) Characterisation of a Pseudomonas aeruginosa twitching motility gene and evidence for a specialised protein export system widespread in eubacteria. Gene 101: 33-44.
39. Winther-Larsen HC, Wolfgang M, Dunham S, van Putten JP, Dorward D, Løvold C et al. (2005) A conserved set of pilin-like molecules controls type IV pilus dynamics and organelle-associated functions in Neisseria gonorrhoeae. Mol Microbiol 56: 903-917.
40. Yang Z & Bielawski JP (2000) Statistical methods for detecting molecular adaptation. Trends Ecol Evol 15: 496-503.
41. Yang Z, Wong WS & Nielsen R (2005) Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 22: 1107-1118.